You are here
Controlled Drugs National Group
The group considers national controlled drugs governance in England.
It provides collaboration, consistency and assurance to government by:
- sharing intelligence
- highlighting good practice and areas of concern
- reporting on the impact of controlled drugs arrangements.
Membership of the national group
- Care Quality Commission
- Department of Health
- General Medical Council
- General Pharmaceutical Council
- Health and Social Care Information Centre
- Her Majesty's Inspectorate of Prisons for England and Wales
- Medicines Advice (Medicines and Prescribing Centre) National Institute for Health and Care Excellence
- Medicines and Healthcare products Regulatory Agency
- Ministry of Defence
- National Police Chiefs’ Council
- NHS Counter Fraud Authority
- NHS England (including Health and Justice Commissioning)
- The Home Office
- UK Anti-doping
- Veterinary Medicines Directorate
Four sub-groups provide expert advice to the national group and issue newsletters. The sub-groups cover these aspects of controlled drugs:
- theft and fraud
- monitoring prescribing
- safe prescribing, dispensing and administration
- policy and operational issues
Subgroup members are from the national group as well as invited specialists.
These report on the sub-groups' findings and signpost guidance.
Previous newsletters and guidance
See our earlier newsletters and guidance on safety incidents and checklists on the National Archives.
- Last updated:
- 13 July 2017